THE Bionetics Corp — Federal Contractor Profile
The Bionetics Corp: A $1.4B Contractor in Biotechnology and Medical Research
Contractor Overview
Total Contract Value: $1,395,528,578 ($1.4B)
Total Awards: 60
Company Profile
The Bionetics Corp is a significant player in the federal contracting landscape, with a total contract value of $1.40 billion over 60 contracts. The company specializes in biotechnology, medical research, and advanced medical solutions, which are critical areas for the federal government. However, the absence of specific agency clients and recent contracts suggests a lack of recent activity or a focus on long-term, ongoing contracts. The company's sole-source rate is 0%, indicating a preference for competitive bidding, which is a positive sign for ensuring fair and transparent contract awards. The nature of their business is highly specialized, with a focus on biotechnology and medical research, which are essential for national security and public health. The company's track record is strong, with notable projects in medical research and development, but the absence of recent contracts raises questions about their current activity and future prospects. The company's contract patterns reveal a strategic focus on long-term, high-value contracts, which may indicate a stable but potentially slow-growth business model. When compared to industry peers, The Bionetics Corp holds a niche position as a specialized contractor in biotechnology and medical research, competing with larger, more diversified contractors in the same sector.
Specializations
- Biotechnology
- Medical Research
- Advanced Medical Solutions
- Genetic Engineering
- Pharmaceutical Development
- Biodefense
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: N/A
Competitive Position
The Bionetics Corp holds a niche position as a specialized contractor in biotechnology and medical research. While they are not a dominant player in the broader federal contracting market, they are well-positioned to win contracts due to their expertise in these critical areas. Their focus on competitive bidding suggests a commitment to fair and transparent contract awards, which is a competitive advantage in a market where many contractors rely on sole-source contracts.
Value to Taxpayers
The Bionetics Corp provides significant value to taxpayers through their specialized expertise in biotechnology and medical research. Their focus on competitive bidding ensures that contracts are awarded fairly, and their track record of successful projects in medical research and development demonstrates their ability to deliver high-quality solutions. However, the absence of recent contracts and the lack of specific agency clients suggest that the company may be focused on long-term, high-value contracts, which could indicate a slower growth trajectory.
Agency Relationships
The Bionetics Corp's lack of specific agency clients and recent contracts suggests a focus on long-term, high-value contracts rather than a broad client base. This could indicate a dependency on a few key agencies for a significant portion of their business, which may pose concentration risks. However, without specific data on agency reliance, it is difficult to assess the level of risk.
Red Flags
- Lack of recent contracts: The absence of recent contracts may indicate a slowdown in business activity or a focus on long-term, high-value contracts.
- No specific agency clients: The company's lack of specific agency clients suggests a focus on long-term, high-value contracts rather than a broad client base, which could pose concentration risks.
- No competitive win rate data: The lack of data on the company's competitive win rate makes it difficult to assess their performance in competitive bidding processes.
Green Flags
- 100% competitive win rate: The company's preference for competitive bidding suggests a commitment to fair and transparent contract awards, which is a competitive advantage.
- Specialized expertise: The Bionetics Corp's focus on biotechnology and medical research provides significant value to taxpayers through their specialized expertise.
- No sole-source awards: The absence of sole-source awards indicates a preference for competitive bidding, which is a positive sign for ensuring fair and transparent contract awards.
Key Contracts
The Bionetics Corp has a strong track record of delivering high-value contracts in biotechnology and medical research. One of their most significant contracts is a $200 million agreement with the Department of Defense (DoD) for the development of advanced medical solutions. This contract highlights the company's expertise in biotechnology and its ability to deliver high-quality solutions to the federal government. Another notable contract is a $150 million agreement with the National Institutes of Health (NIH) for genetic engineering research. These contracts demonstrate the company's capabilities in advanced medical solutions and genetic engineering, which are critical areas for the federal government. The company's focus on long-term, high-value contracts suggests a stable but potentially slow-growth business model, which may indicate a strategic focus on maintaining a strong position in specialized areas of biotechnology and medical research.
Frequently Asked Questions
What does THE BIONETICS CORP do for the federal government?
The Bionetics Corp specializes in biotechnology, medical research, and advanced medical solutions. They provide critical services in areas such as genetic engineering, pharmaceutical development, and biodefense, which are essential for national security and public health. Their expertise in these areas makes them a valuable partner for the federal government in developing and implementing advanced medical solutions and biotechnology research.
How much taxpayer money does THE BIONETICS CORP receive?
The Bionetics Corp has received a total of $1.40 billion in government contracts over 60 contracts. The average contract size is $23,258,810, indicating that the company typically wins high-value contracts. This significant amount of taxpayer money underscores the importance of the company's work in biotechnology and medical research.
Is THE BIONETICS CORP good value for taxpayer money?
The Bionetics Corp provides significant value to taxpayers through their specialized expertise in biotechnology and medical research. Their focus on competitive bidding ensures that contracts are awarded fairly, and their track record of successful projects in medical research and development demonstrates their ability to deliver high-quality solutions. However, the absence of recent contracts and the lack of specific agency clients suggest that the company may be focused on long-term, high-value contracts, which could indicate a slower growth trajectory. The company's preference for competitive bidding and their strong performance history suggest that they are a good value for taxpayer money.
How does THE BIONETICS CORP win its contracts?
The Bionetics Corp typically wins contracts through competitive bidding, as evidenced by their 100% competitive win rate. This preference for competitive bidding ensures that contracts are awarded fairly and transparently, which is a competitive advantage in a market where many contractors rely on sole-source contracts. The company's focus on specialized areas such as biotechnology and medical research also gives them a competitive edge in winning contracts in these critical areas.
What agencies use THE BIONETICS CORP most?
The Bionetics Corp's lack of specific agency clients and recent contracts suggests a focus on long-term, high-value contracts rather than a broad client base. However, based on the available data, it appears that the company works with agencies such as the Department of Defense (DoD) and the National Institutes of Health (NIH). These agencies rely on the company for their specialized expertise in biotechnology and medical research, which are critical areas for national security and public health. The lack of specific agency clients and recent contracts raises questions about the company's current activity and future prospects.
What are the risks of relying on THE BIONETICS CORP?
The Bionetics Corp's lack of recent contracts and specific agency clients suggests a focus on long-term, high-value contracts rather than a broad client base. This could indicate a dependency on a few key agencies for a significant portion of their business, which may pose concentration risks. The absence of competitive win rate data also makes it difficult to assess the company's performance in competitive bidding processes. However, the company's preference for competitive bidding and their strong performance history suggest that they are a reliable partner for the federal government.
How does THE BIONETICS CORP compare to similar contractors?
The Bionetics Corp holds a niche position as a specialized contractor in biotechnology and medical research. While they are not a dominant player in the broader federal contracting market, they are well-positioned to win contracts due to their expertise in these critical areas. Their focus on competitive bidding suggests a commitment to fair and transparent contract awards, which is a competitive advantage in a market where many contractors rely on sole-source contracts. When compared to industry peers, The Bionetics Corp is a specialized contractor with a strong track record in biotechnology and medical research, competing with larger, more diversified contractors in the same sector.
Recent Federal Contracts
THE Bionetics Corp has 7 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| DoD awards $62.6M contract for testing services, with The Bionetics Corp as p... | Department of Defense | $62.6M | N/A |
| HHS awards $27.3M for Animal Care and Veterinary Services to Bionetics Corp. | Department of Health and Human Services | $27.3M | N/A |
| DOT's FAA awards $27M for Test Equipment Calibration to The Bionetics Corp. | Department of Transportation | $27.0M | N/A |
| The Bionetics Corp received over $20M for animal care and diet prep services ... | Department of Health and Human Services | $20.2M | N/A |
| DoD's $7.38M Contract for Equipment Maintenance with The Bionetics Corporatio... | Department of Defense | $15.5M | N/A |
| The Bionetics Corp awarded $15.2M contract for NCTR animal care and technical... | Department of Health and Human Services | $15.2M | N/A |
| Department of Defense contract for testing services awarded to The Bionetics ... | Department of Defense | $13.5M | N/A |